| 000 | 01670 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517180818.0 | ||
| 264 | 0 | _c20190625 | |
| 008 | 201906s 0 0 eng d | ||
| 022 | _a2045-2322 | ||
| 024 | 7 |
_a10.1038/s41598-017-13376-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aEken, Ahmet | |
| 245 | 0 | 0 |
_aS1P _h[electronic resource] |
| 260 |
_bScientific reports _c10 2017 |
||
| 300 |
_a12905 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aAutoimmunity |
| 650 | 0 | 4 | _aCase-Control Studies |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 |
_aEncephalomyelitis, Autoimmune, Experimental _ximmunology |
| 650 | 0 | 4 |
_aFingolimod Hydrochloride _xpharmacology |
| 650 | 0 | 4 | _aGene Deletion |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInflammation _xpathology |
| 650 | 0 | 4 |
_aLymphadenopathy _xpathology |
| 650 | 0 | 4 |
_aLymphoid Tissue _xpathology |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMultiple Sclerosis _xdrug therapy |
| 650 | 0 | 4 | _aOrgan Specificity |
| 650 | 0 | 4 | _aPhenotype |
| 650 | 0 | 4 |
_aReceptors, Lysosphingolipid _xgenetics |
| 650 | 0 | 4 |
_aT-Lymphocytes, Regulatory _ximmunology |
| 650 | 0 | 4 |
_aTh17 Cells _ximmunology |
| 650 | 0 | 4 | _aTranscription, Genetic |
| 700 | 1 | _aDuhen, Rebekka | |
| 700 | 1 | _aSingh, Akhilesh K | |
| 700 | 1 | _aFry, Mallory | |
| 700 | 1 | _aBuckner, Jane H | |
| 700 | 1 | _aKita, Mariko | |
| 700 | 1 | _aBettelli, Estelle | |
| 700 | 1 | _aOukka, Mohamed | |
| 773 | 0 |
_tScientific reports _gvol. 7 _gno. 1 _gp. 12905 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1038/s41598-017-13376-2 _zAvailable from publisher's website |
| 999 |
_c27671268 _d27671268 |
||